Concepedia

Yuki Naitou

YN

5

Publications

131

Citations

5

H-Index

2003

Active since

Affiliations

Astellas Pharma (Japan)(Current)

Yuki Naitou is an author at Astellas Pharma (Japan) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

2003–2008

5

Publications

5

Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist

Yasuharu Kimura, Ken-ichi Hatanaka, Yuki Naitou et al. · European Journal of Pharmacology · 2003 · 52 citations · Full text

, , +5

Synthesis and structure–activity relationships of a series of substituted 2-(1H-furo[2,3-g]indazol-1-yl)ethylamine derivatives as 5-HT2C receptor agonists

Itsuro Shimada, Kyoichi Maeno, Kenichi Kazuta et al. · Bioorganic & Medicinal Chemistry · 2007 · 35 citations · Full text

, , +6

5-HT2C receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats

Yasuharu Kimura, Yuki Naitou, Fumikazu Wanibuchi et al. · European Journal of Pharmacology · 2008 · 20 citations

, , +14

Characterization of Intracavernous Pressure Increase Induced by Ym348, a Novel 5-HT <sub>2C</sub> Receptor Agonist, in Anesthetized Rats

Yasuharu Kimura, Yuki Naitou, Fumikazu Wanibuchi et al. · The Journal of Urology · 2006 · 14 citations

Synthesis and structure–activity relationships of a series of benzazepine derivatives as 5-HT2C receptor agonists

Itsuro Shimada, Kyoichi Maeno, Yutaka Kondoh et al. · Bioorganic & Medicinal Chemistry · 2007 · 10 citations · Full text

, , +7

Rows per page

1–5 of 5